Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan. (Q42288046)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802888%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802888%20AND%20SRC:MED&resulttype=core&format=json

population-based cohort study

3 March 2020

main subject

1 reference

1 reference

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802888%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

C-S Hsu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802888%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Y-C Chao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802888%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

H H Lin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802888%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Y-C Fan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802888%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

C-J Huang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802888%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

P-S Tsai

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802888%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

English

0 references

publication date

26 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802888%20AND%20SRC:MED&resulttype=core&format=json

Alimentary Pharmacology & Therapeutics

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802888%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802888%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

415-423

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802888%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802888%20AND%20SRC:MED&resulttype=core&format=json

Transmission of hepatitis C virus in Asia: past and present perspectives

3 March 2020

cites work

1 reference

Hepatitis C, metabolic syndrome, and inflammatory markers: results from the Third National Health and Nutrition Examination Survey [NHANES III].

21 January 2018

1 reference

Metabolic profiles in patients with chronic hepatitis C: a case-control study

21 January 2018

1 reference

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States

21 January 2018

1 reference

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

21 January 2018

1 reference

High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C.

21 January 2018

1 reference

Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening

21 January 2018

1 reference

Hepatitis C and carotid atherosclerosis: a retrospective analysis

21 January 2018

1 reference

Hepatitis C virus and atherosclerosis in patients with type 2 diabetes

21 January 2018

1 reference

The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals

21 January 2018

1 reference

Does hepatitis C virus infection increase risk for stroke? A population-based cohort study

21 January 2018

1 reference

Diagnosis, management, and treatment of hepatitis C: an update

21 January 2018

1 reference

EASL Clinical Practice Guidelines: management of hepatitis C virus infection

21 January 2018

1 reference

Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection

21 January 2018

1 reference

Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2.

21 January 2018

1 reference

Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C.

21 January 2018

1 reference

Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy

21 January 2018

1 reference

Comparison of a 6-month course peginterferon alpha-2b plus ribavirin and interferon alpha-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan.

21 January 2018

1 reference

Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial.

21 January 2018

1 reference

A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C

21 January 2018

1 reference

The effects of HCV infection and management on health-related quality of life

21 January 2018

1 reference

Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals?

21 January 2018

1 reference

Evidence for a cerebral effect of the hepatitis C virus

21 January 2018

1 reference

Hepatitis C virus infection and increased risk of cerebrovascular disease.

21 January 2018

1 reference

Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan

21 January 2018

1 reference

Genotypes of hepatitis C virus in Taiwan and the progression of liver disease

21 January 2018

1 reference